Exalt Single-use Duodenoscope Vs Reusable Scope, a Randomized Controlled Trial
NCT06895785 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2025-03-26
Summary
This randomized controlled trial (RCT) is designed to evaluate the new generation Exalt Model disposable duodenoscope compared to the reusable scope in terms of feasibility, ease of use, adverse events, number of crossover events, and infection rates.
Conditions
- Biliary Diseases
- Pancreatic Duct Disorder
Interventions
- DEVICE
-
Exalt Model D
Exalt Model D single-use duodenoscope will be used in ERCP
- DEVICE
-
Reusable
Standard reusable duodenoscope will be used in ERCP
Sponsors & Collaborators
-
Rush University Medical Center
lead OTHER
Principal Investigators
-
Neal A Mehta, MD · Rush University Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-02-21
- Primary Completion
- 2030-02-28
- Completion
- 2030-05-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis
NCT01766713 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4)
NCT02227459 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
NCT02026401 ·Status: COMPLETED ·Phase: PHASE2
-
Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)
NCT02443116 ·Status: COMPLETED ·Phase: PHASE2
-
Ezetimibe-Ursodiol Combination Therapy on Biomarkers of Liver Function and Sterol Balance in Subjects With NAFLD
NCT02244944 ·Status: TERMINATED ·Phase: PHASE2
-
Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1
NCT04618575 ·Status: UNKNOWN ·Phase: PHASE4
-
Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis
NCT00470171 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Mesenchymal Stem Cells-derived Exosomes in Decompensated Liver Cirrhosis
NCT05871463 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison of 19g FNA and 19g FNB Needles for EUS-LB
NCT03408171 ·Status: COMPLETED ·Phase: NA
-
A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK
NCT06269484 ·Status: COMPLETED ·Phase: PHASE2
-
Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases
NCT06891365 ·Status: RECRUITING ·Phase: PHASE1
-
An Follow-Up Study of Liver Cirrhosis
NCT03472742 ·Status: COMPLETED
-
The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and Steatosis
NCT03957070 ·Status: COMPLETED ·Phase: NA
-
Cardiox Liver Function Test Pivotal Trial
NCT02552901 ·Status: WITHDRAWN ·Phase: PHASE3
-
F573 for Injection for the Treatment of Liver Injury/Failure
NCT05689645 ·Status: RECRUITING ·Phase: PHASE2
-
Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites
NCT01349335 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis
NCT02421094 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124
NCT03087968 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology
NCT05370053 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study
NCT06078722 ·Status: UNKNOWN
-
Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.
NCT04579874 ·Status: COMPLETED ·Phase: NA
-
Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis
NCT06302049 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Assessment of Non-Invasive Testing in Major Liver-Related Outcomes
NCT06986447 ·Status: ENROLLING_BY_INVITATION
-
Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
NCT00004842 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects
NCT07024212 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2